Ingevity (NGVT) Financials

$71.47 +0.21 (+0.30%)

Closing price 03:59 PM Eastern

Extended Trading

$71.40 -0.07 (-0.10%)

As of 05:41 PM Eastern

Annual Income Statements for Ingevity

This table shows Ingevity's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	80	35	127	169	184	181	118	212	-5.40	-430	-167
Consolidated Net Income / (Loss)	84	44	145	182	184	181	118	212	-5.40	-430	-167
Net Income / (Loss) Continuing Operations	84	44	145	182	184	181	118	212	106	-121	-150
Total Pre-Tax Income	137	87	175	222	228	235	163	270	130	-141	-142
Total Operating Income	156	102	191	253	271	273	290	324	201	-43	-44
Total Gross Profit	275	274	329	417	482	466	513	570	445	465	462
Total Revenue	958	908	972	1,134	1,293	1,216	1,392	1,668	1,216	1,200	1,168
Operating Revenue	958	908	972	1,134	1,293	1,216	1,392	1,668	1,216	1,200	1,168
Total Cost of Revenue	683	634	643	717	811	751	879	1,098	771	735	706
Operating Cost of Revenue	683	634	643	717	811	751	879	1,098	771	735	706
Total Operating Expenses	120	173	138	164	212	192	222	246	244	507	506
Selling, General & Admin Expense	110	114	106	132	163	149	179	199	162	158	171
Research & Development Expense	17	18	20	22	20	23	26	30	25	25	28
Other Operating Expenses / (Income)	-	-	0.90	-	1.80	-	-	12	53	18	13
Impairment Charge	-	-	-	-	-	-	-	0.00	0.00	307	293
Restructuring Charge	-7.50	41	11	10	27	20	17	5.00	3.60	0.30	0.00
Total Other Income / (Expense), net	-19	-15	-16	-31	-43	-38	-128	-54	-71	-98	-98
Interest Expense	20	19	18	33	55	47	52	62	93	98	78
Interest & Investment Income	0.00	1.40	2.30	3.40	7.70	4.90	4.00	7.50	6.30	7.70	5.20
Other Income / (Expense), net	1.00	3.20	-0.50	-1.00	4.30	4.10	-80	-	16	-7.90	-25
Income Tax Expense	52	43	30	40	44	54	45	58	24	-19	8.20
Net Income / (Loss) Discontinued Operations	-	-	-	-	-	-	-	-	-111	-309	-17
Basic Earnings per Share	$1.89	$0.83	$3.00	$4.02	$4.39	$4.39	$2.97	$5.54	($0.15)	($11.85)	($4.61)
Weighted Average Basic Shares Outstanding	42.10M	42.11M	42.13M	42.04M	41.83M	40.47M	39.00M	37.15M	36.24M	36.35M	35.29M
Diluted Earnings per Share	$1.89	$0.83	$2.97	$3.97	$4.35	$4.37	$2.95	$5.50	($0.15)	($11.85)	($4.61)
Weighted Average Diluted Shares Outstanding	42.10M	42.11M	42.13M	42.04M	41.83M	40.47M	39.00M	37.15M	36.24M	36.35M	35.29M
Weighted Average Basic & Diluted Shares Outstanding	42.10M	42.11M	42.13M	42.04M	41.83M	40.47M	39.00M	37.15M	36.24M	36.35M	35.29M

This table shows Ingevity's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	25	-117	-56	-284	-107	17	21	-147	44	-85	60
Consolidated Net Income / (Loss)	25	-117	-56	-284	-107	17	21	-147	44	-85	60
Net Income / (Loss) Continuing Operations	25	-117	-56	-284	48	17	29	-147	41	-65	23
Total Pre-Tax Income	32	-154	-72	-335	54	8.80	38	-143	62	-88	30
Total Operating Income	57	-109	-17	-288	84	55	57	-120	82	-56	69
Total Gross Profit	129	60	100	123	132	102	112	138	134	76	116
Total Revenue	446	372	340	391	334	299	248	365	333	185	258
Operating Revenue	446	372	340	391	334	299	248	365	333	185	258
Total Cost of Revenue	317	312	240	267	202	197	136	227	199	109	142
Operating Cost of Revenue	317	312	240	267	202	197	136	227	199	109	142
Total Operating Expenses	73	168	117	411	47	47	55	258	52	133	48
Selling, General & Admin Expense	40	43	47	41	38	39	42	44	44	40	41
Research & Development Expense	7.80	7.20	6.80	7.30	6.20	7.30	7.00	7.80	7.00	5.90	6.70
Restructuring Charge	25	126	0.30	-0.20	-0.10	87	1.90	0.00	0.00	-	0.50
Total Other Income / (Expense), net	-24	-45	-55	-47	-30	-47	-19	-23	-20	-32	-38
Interest & Investment Income	-23	71	-22	-23	-24	77	-19	-19	-18	62	-16
Other Income / (Expense), net	-1.30	-	-32	-24	-6.50	-	-	-4.30	-1.20	-15	-22
Income Tax Expense	6.90	-37	-16	-51	6.50	-7.80	8.50	3.80	21	-23	6.80
Net Income / (Loss) Discontinued Operations	-	-	-	-	-155	-	-8.60	-	2.70	-	36
Basic Earnings per Share	$0.70	($3.19)	($1.54)	($7.81)	($2.95)	$0.45	$0.56	($4.02)	$1.20	($2.35)	$1.70
Weighted Average Basic Shares Outstanding	36.23M	36.24M	36.33M	36.35M	36.35M	36.35M	36.46M	36.47M	35.96M	35.29M	34.77M
Diluted Earnings per Share	$0.69	($3.16)	($1.54)	($7.81)	($2.94)	$0.45	$0.56	($4.02)	$1.18	($2.33)	$1.66
Weighted Average Diluted Shares Outstanding	36.23M	36.24M	36.33M	36.35M	36.35M	36.35M	36.46M	36.47M	35.96M	35.29M	34.77M
Weighted Average Basic & Diluted Shares Outstanding	36.23M	36.24M	36.33M	36.35M	36.35M	36.35M	36.46M	36.47M	35.96M	35.29M	34.77M

This table details how cash moves in and out of Ingevity's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	9.90	-1.90	41	-10	-13	194	20	-196	28	-25	26
Net Cash From Operating Activities	72	128	174	252	276	352	293	313	205	129	331
Net Cash From Continuing Operating Activities	72	128	157	252	276	352	293	313	205	129	331
Net Income / (Loss) Continuing Operations	84	44	145	182	184	181	118	212	-5.40	-430	-167
Consolidated Net Income / (Loss)	84	44	145	182	184	181	118	212	-5.40	-430	-167
Depreciation Expense	35	39	40	57	85	100	110	109	123	108	106
Non-Cash Adjustments To Reconcile Net Income	-2.80	53	1.90	34	50	31	149	78	205	598	419
Changes in Operating Assets and Liabilities, net	-44	-2.30	-19	-14	-43	47	-84	-85	-117	-148	-28
Net Cash From Investing Activities	-89	-126	-59	-414	-658	-111	-139	-552	-77	-80	-58
Net Cash From Continuing Investing Activities	-89	-126	-59	-414	-658	-111	-139	-552	-77	-80	-58
Purchase of Property, Plant & Equipment	-101	-57	-53	-94	-115	-82	-104	-143	-110	-78	-58
Purchase of Investments	0.00	-70	-4.00	-2.00	-	-	-	-77	29	-0.30	-16
Sale of Property, Plant & Equipment	-	-	-	-	-	-	-	-	0.00	0.00	3.60
Other Investing Activities, net	0.60	0.00	-3.00	-4.10	-5.60	-29	0.50	-2.20	3.40	-1.60	13
Net Cash From Financing Activities	27	-3.40	-58	154	369	-50	-133	48	-100	-70	-252
Net Cash From Continuing Financing Activities	27	-3.40	-58	154	369	-50	-133	48	-100	-70	-252
Repayment of Debt	-5.80	-13	-270	-7.10	-789	-882	-25	-972	-383	-471	-484
Repurchase of Common Equity	0.00	0.00	-6.60	-47	-6.40	-88	-109	-145	-92	0.00	-56
Issuance of Debt	7.10	412	231	304	1,175	896	0.00	1,165	376	405	291
Other Financing Activities, net	29	52	-0.70	-0.40	-10	24	1.60	1.00	-0.80	-4.10	-3.60
Effect of Exchange Rate Changes	-	-	-	-1.40	0.20	2.20	-1.70	-6.00	-0.30	-4.20	4.50
Cash Interest Paid	6.50	15	16	26	48	40	48	55	83	85	70
Cash Income Taxes Paid	1.40	22	62	35	15	47	54	55	30	27	11

This table details how cash moves in and out of Ingevity's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	17	18	-6.80	20	28	-67	5.80	16	25	-20	43
Net Cash From Operating Activities	105	46	-12	30	47	65	25	79	130	97	-2.00
Net Cash From Continuing Operating Activities	105	46	-12	30	47	65	25	79	130	97	-2.00
Net Income / (Loss) Continuing Operations	25	-117	-56	-284	-107	17	21	-147	44	-85	60
Consolidated Net Income / (Loss)	25	-117	-56	-284	-107	17	21	-147	44	-85	60
Depreciation Expense	31	31	30	27	26	25	25	26	28	28	23
Non-Cash Adjustments To Reconcile Net Income	76	158	111	367	152	-16	6.30	216	-0.40	177	-18
Changes in Operating Assets and Liabilities, net	-26	-26	-96	-81	-25	39	-26	-16	59	-23	-67
Net Cash From Investing Activities	-32	-25	-16	-18	-17	-28	-12	-2.80	-28	-15	106
Net Cash From Continuing Investing Activities	-32	-25	-16	-18	-17	-28	-12	-2.80	-28	-15	106
Purchase of Property, Plant & Equipment	-34	-29	-17	-18	-18	-25	-10	-12	-12	-24	-10
Sale of Property, Plant & Equipment	-	-	0.00	-	-	-	3.60	-	-	-	0.00
Divestitures	-	-	-	-	-	-	0.00	-	-	-	93
Other Investing Activities, net	3.50	4.50	0.30	0.30	0.60	-2.80	-5.10	9.40	8.40	0.30	24
Net Cash From Financing Activities	-53	-6.50	23	10	-6.30	-98	-11	-63	-95	-83	-62
Net Cash From Continuing Financing Activities	-53	-6.50	23	10	-6.30	-98	-11	-63	-95	-83	-62
Repayment of Debt	-95	-143	-55	-20	-44	-351	-100	-129	-121	-134	-722
Repurchase of Common Equity	-	-	-	-	-	-	0.00	-	-	-31	-52
Issuance of Debt	42	137	81	31	38	254	92	66	51	82	714
Other Financing Activities, net	0.30	-0.10	-3.00	-0.40	-0.40	-0.30	-3.00	-0.20	0.10	-0.50	-1.30
Cash Interest Paid	18	25	17	25	19	24	15	23	14	20	11
Cash Income Taxes Paid	4.30	1.80	2.90	19	1.80	2.90	4.40	1.20	1.50	3.80	2.50

This table presents Ingevity's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	779	833	930	1,315	2,142	2,335	2,469	2,737	2,623	2,023	1,651
Total Current Assets	296	295	369	423	463	629	725	683	659	493	454
Cash & Equivalents	32	31	88	78	57	258	275	77	96	68	78
Accounts Receivable	95	90	100	119	150	-	-	225	-	132	127
Inventories, net	149	151	160	191	213	189	241	335	309	196	186
Prepaid Expenses	20	24	21	35	44	34	47	47	72	51	47
Other Current Nonoperating Assets	-	-	-	-	-	-	-	-	-	47	16
Plant, Property, & Equipment, net	438	423	439	524	0.00	0.00	0.00	799	762	643	608
Total Noncurrent Assets	45	115	122	369	1,679	1,706	1,744	1,255	1,203	887	589
Long-Term Investments	-	-	-	-	-	-	-	-	-	-	84
Goodwill	12	12	12	131	436	445	442	519	528	175	4.30
Intangible Assets	10	7.30	4.90	126	396	373	338	405	336	279	176
Noncurrent Deferred & Refundable Income Taxes	0.00	3.40	3.40	2.90	5.00	8.10	6.80	5.70	12	118	117
Other Noncurrent Operating Assets	23	92	102	110	841	879	958	326	327	293	188
Other Noncurrent Nonoperating Assets	-	-	-	-	-	-	-	-	-	22	20
Total Liabilities & Shareholders' Equity	779	833	930	1,315	2,142	2,335	2,469	2,737	2,623	2,023	1,651
Total Liabilities	261	698	652	977	1,611	1,692	1,795	2,038	1,992	1,827	1,621
Total Current Liabilities	100	137	153	183	216	223	269	304	363	264	341
Short-Term Debt	9.40	7.50	9.40	11	23	26	20	0.90	84	61	47
Accounts Payable	65	79	83	93	99	104	126	175	158	95	92
Accrued Expenses	15	19	20	37	33	47	52	54	72	58	148
Current Deferred & Payable Income Tax Liabilities	0.80	5.30	1.50	0.50	15	5.30	6.20	3.60	9.20	5.60	4.70
Current Employee Benefit Liabilities	10	26	39	42	28	25	48	53	20	27	35
Other Current Liabilities	-	-	-	0.00	17	16	17	17	19	14	12
Other Current Nonoperating Liabilities	-	-	-	-	-	-	-	-	-	2.90	3.10
Total Noncurrent Liabilities	162	561	499	793	1,395	1,469	1,526	1,735	1,629	1,563	1,280
Long-Term Debt	80	481	444	741	1,228	1,267	1,250	1,473	1,383	1,340	1,161
Noncurrent Deferred & Payable Income Tax Liabilities	74	70	41	37	100	117	115	107	71	56	55
Other Noncurrent Operating Liabilities	7.20	10	13	15	67	85	162	156	175	164	63
Other Noncurrent Nonoperating Liabilities	-	-	-	-	-	-	-	-	-	3.20	0.70
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	517	135	278	339	531	642	674	698	631	195	30
Total Preferred & Common Equity	514	127	264	339	531	642	674	698	631	195	30
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	514	127	264	339	531	642	674	698	631	195	30
Common Stock	0.00	130	141	99	113	122	137	153	165	177	196
Retained Earnings	0.00	16	143	314	497	678	796	1,008	1,002	572	405
Treasury Stock	0.00	-0.30	-7.70	-56	-75	-162	-272	-416	-510	-513	-572
Accumulated Other Comprehensive Income / (Loss)	-17	-19	-12	-18	-5.00	4.70	13	-47	-27	-41	0.50

This table presents Ingevity's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024	3/31/2025	6/30/2025	9/30/2025	3/31/2026
Total Assets	2,335	2,772	2,828	2,767	2,567	2,276	2,212	2,056	1,878	1,834	1,650
Total Current Assets	645	716	764	735	669	686	637	530	536	522	582
Cash & Equivalents	72	78	68	85	89	107	136	72	77	83	95
Restricted Cash	-	-	-	-	-	-	-	-	-	-	85
Accounts Receivable	-	240	260	217	191	213	190	164	193	168	151
Inventories, net	282	361	387	387	326	302	261	245	220	194	204
Prepaid Expenses	43	37	50	47	64	63	50	49	45	46	47
Other Current Nonoperating Assets	-	-	-	-	-	-	-	-	-	31	0.00
Plant, Property, & Equipment, net	721	805	801	800	727	722	671	656	655	630	600
Total Noncurrent Assets	970	1,251	1,263	1,232	1,171	868	904	870	687	682	469
Long-Term Investments	-	-	-	-	-	-	-	-	-	-	0.00
Goodwill	388	522	527	520	526	177	187	181	4.30	4.30	4.30
Intangible Assets	272	399	394	376	303	296	299	277	279	268	168
Noncurrent Deferred & Refundable Income Taxes	6.90	7.40	7.00	6.10	24	81	114	120	119	93	101
Other Noncurrent Operating Assets	303	323	335	331	319	315	304	293	285	293	196
Other Noncurrent Nonoperating Assets	-	-	-	-	-	-	-	-	-	24	0.00
Total Liabilities & Shareholders' Equity	2,335	2,772	2,828	2,767	2,567	2,276	2,212	2,056	1,878	1,834	1,650
Total Liabilities	1,702	2,047	2,114	2,048	1,999	1,991	1,997	1,822	1,757	1,696	1,611
Total Current Liabilities	290	279	311	305	352	358	361	265	393	412	409
Short-Term Debt	0.90	0.90	0.90	3.00	85	103	101	60	95	102	122
Accounts Payable	165	174	204	197	153	142	97	108	102	101	85
Accrued Expenses	57	55	64	65	71	70	117	57	151	159	165
Current Deferred & Payable Income Tax Liabilities	6.80	11	5.10	5.40	8.00	2.70	4.70	4.20	5.80	6.30	3.90
Current Employee Benefit Liabilities	45	22	20	17	17	21	24	19	26	29	20
Other Current Liabilities	16	16	18	18	19	19	18	16	15	10	13
Other Current Nonoperating Liabilities	-	-	-	-	-	-	-	-	-	4.60	0.00
Total Noncurrent Liabilities	1,411	1,768	1,803	1,743	1,647	1,634	1,636	1,557	1,364	1,284	1,202
Long-Term Debt	1,153	1,503	1,526	1,470	1,409	1,401	1,398	1,333	1,236	1,159	1,082
Noncurrent Deferred & Payable Income Tax Liabilities	107	108	110	105	64	62	66	59	57	56	53
Other Noncurrent Operating Liabilities	151	158	168	168	174	171	173	165	71	63	66
Other Noncurrent Nonoperating Liabilities	-	-	-	-	-	-	-	-	-	6.80	0.00
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	634	726	714	719	568	285	215	235	121	138	39
Total Preferred & Common Equity	634	726	714	719	568	285	215	235	121	138	39
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	634	726	714	719	568	285	215	235	121	138	39
Common Stock	148	159	164	163	170	172	175	181	186	192	204
Retained Earnings	992	1,058	1,094	1,119	946	663	555	593	446	490	465
Treasury Stock	-411	-453	-510	-510	-512	-512	-513	-515	-515	-541	-628
Accumulated Other Comprehensive Income / (Loss)	-95	-39	-34	-54	-36	-38	-3.50	-24	4.20	-2.40	-1.60

This table displays calculated financial ratios and metrics derived from Ingevity's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-7.46%	-5.22%	7.06%	16.58%	14.05%	-5.94%	14.42%	19.89%	1.43%	-16.88%	-2.71%
EBITDA Growth	-23.76%	-27.93%	72.06%	27.20%	19.30%	2.97%	-13.52%	35.05%	-53.85%	-268.85%	-35.41%
EBIT Growth	-28.33%	-33.01%	81.70%	32.00%	9.22%	0.91%	-24.09%	53.87%	-76.26%	-679.32%	-36.90%
NOPAT Growth	-32.19%	-45.99%	205.84%	30.43%	5.31%	-3.32%	-0.06%	20.67%	-77.26%	-433.78%	-3.53%
Net Income Growth	-36.43%	-47.33%	227.03%	25.21%	1.05%	-1.25%	-34.90%	79.17%	-102.55%	-7,868.52%	61.17%
EPS Growth	-38.24%	-56.08%	257.83%	33.67%	9.57%	0.46%	-32.49%	86.44%	-102.73%	-7,800.00%	61.10%
Operating Cash Flow Growth	-47.87%	77.15%	36.28%	44.58%	9.40%	27.82%	-16.77%	6.85%	-34.56%	-37.30%	157.54%
Free Cash Flow Firm Growth	0.00%	107.06%	220.22%	-250.73%	-202.51%	152.31%	-14.61%	-178.37%	186.88%	87.52%	-39.50%
Invested Capital Growth	0.00%	3.15%	8.52%	57.54%	70.21%	-2.75%	-0.58%	25.60%	-4.41%	-23.69%	-23.02%
Revenue Q/Q Growth	0.00%	1.17%	1.95%	4.53%	1.96%	1.86%	0.75%	2.94%	-0.70%	-4.93%	-11.82%
EBITDA Q/Q Growth	0.00%	-5.62%	12.37%	1.62%	6.77%	2.55%	-8.43%	-2.06%	-42.88%	-3.44%	166.91%
EBIT Q/Q Growth	0.00%	-3.41%	11.99%	5.18%	5.41%	4.96%	-12.84%	-3.31%	-66.17%	-1.30%	56.77%
NOPAT Q/Q Growth	0.00%	10.28%	33.38%	-3.67%	1.27%	0.16%	-5.53%	-2.82%	-67.23%	37.31%	-2.80%
Net Income Q/Q Growth	0.00%	8.29%	33.33%	-3.14%	1.21%	0.95%	-12.39%	-6.08%	-104.25%	23.67%	-153.57%
EPS Q/Q Growth	0.00%	295.24%	6.83%	0.51%	1.64%	1.16%	-10.61%	-5.66%	-104.36%	23.35%	-150.54%
Operating Cash Flow Q/Q Growth	0.00%	15.02%	-6.99%	21.68%	-0.04%	23.82%	-20.79%	7.62%	-20.32%	16.59%	10.92%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	-14.11%	10.53%	-8.40%	45.91%	-24.55%	-188.66%	169.90%	26.96%	11.03%
Invested Capital Q/Q Growth	0.00%	-4.95%	4.31%	-0.05%	2.40%	-2.35%	1.15%	22.11%	-4.95%	-3.11%	-11.22%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	28.74%	30.21%	33.83%	36.77%	37.28%	38.28%	36.85%	34.17%	27.89%	32.33%	39.53%
EBITDA Margin	19.95%	15.17%	24.38%	26.61%	27.83%	30.47%	23.03%	25.94%	11.80%	-23.98%	3.20%
Operating Margin	16.24%	11.20%	19.65%	22.28%	20.92%	22.47%	20.87%	19.42%	4.88%	-19.60%	-3.77%
EBIT Margin	16.34%	11.55%	19.60%	22.19%	21.25%	22.80%	15.13%	19.42%	4.54%	-31.68%	-5.91%
Profit (Net Income) Margin	8.80%	4.89%	14.93%	16.04%	14.21%	14.92%	8.49%	12.68%	-0.32%	-30.60%	-14.31%
Tax Burden Percent	61.76%	51.03%	83.07%	81.97%	80.61%	77.16%	72.54%	78.49%	53.47%	80.34%	117.59%
Interest Burden Percent	87.16%	82.94%	91.71%	88.16%	82.93%	84.78%	77.34%	83.24%	-13.13%	120.22%	205.94%
Effective Tax Rate	38.24%	48.97%	16.93%	18.03%	19.39%	22.84%	27.46%	21.51%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	33.44%	8.89%	25.68%	24.99%	15.92%	12.39%	12.59%	13.51%	2.82%	-10.93%	-2.37%
ROIC Less NNEP Spread (ROIC-NNEP)	-7.66%	5.98%	22.39%	20.14%	12.25%	9.75%	3.47%	9.95%	-1.75%	-28.48%	-13.88%
Return on Net Nonoperating Assets (RNNOA)	-0.85%	4.73%	44.72%	33.98%	26.33%	18.54%	5.36%	17.33%	-3.63%	-93.18%	-146.23%
Return on Equity (ROE)	32.59%	13.62%	70.40%	58.97%	42.25%	30.93%	17.95%	30.84%	-0.81%	-104.11%	-148.60%
Cash Return on Invested Capital (CROIC)	-166.56%	5.79%	17.51%	-19.69%	-36.04%	15.17%	13.18%	-9.18%	7.33%	15.95%	23.64%
Operating Return on Assets (OROA)	20.11%	13.02%	21.63%	22.42%	15.90%	12.39%	8.76%	12.44%	2.87%	-19.18%	-3.76%
Return on Assets (ROA)	10.83%	5.51%	16.48%	16.20%	10.63%	8.11%	4.92%	8.13%	-0.20%	-18.52%	-9.10%
Return on Common Equity (ROCE)	32.35%	13.38%	66.71%	57.63%	42.25%	30.93%	17.95%	30.84%	-0.81%	-104.11%	-148.60%
Return on Equity Simple (ROE_SIMPLE)	16.41%	34.96%	55.02%	53.68%	34.61%	28.25%	17.53%	30.30%	-0.86%	-220.44%	0.00%
Net Operating Profit after Tax (NOPAT)	96	52	159	207	218	211	211	254	58	-193	-31
NOPAT Margin	10.03%	5.71%	16.32%	18.26%	16.86%	17.33%	15.14%	15.24%	3.42%	-13.72%	-2.64%
Net Nonoperating Expense Percent (NNEP)	41.10%	2.91%	3.29%	4.85%	3.67%	2.64%	9.12%	3.57%	4.57%	17.55%	11.50%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	11.71%	2.76%	-12.09%	-2.49%
Cost of Revenue to Revenue	71.26%	69.79%	66.17%	63.23%	62.72%	61.72%	63.15%	65.83%	72.11%	67.67%	60.47%
SG&A Expenses to Revenue	11.47%	12.54%	10.94%	11.68%	12.62%	12.29%	12.89%	11.92%	10.86%	11.85%	14.66%
R&D to Revenue	1.82%	1.94%	2.04%	1.90%	1.52%	1.86%	1.89%	1.82%	1.88%	2.00%	2.43%
Operating Expenses to Revenue	12.50%	19.01%	14.18%	14.48%	16.36%	15.81%	15.98%	14.76%	23.01%	51.93%	43.29%
Earnings before Interest and Taxes (EBIT)	157	105	191	252	275	277	211	324	77	-446	-69
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	191	138	237	302	360	371	320	433	200	-337	37
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	18.19	11.25	10.37	6.89	4.87	4.18	3.77	2.71	7.59	71.66
Price to Tangible Book Value (P/TBV)	0.00	21.53	12.04	42.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.00	2.54	3.05	3.10	2.83	2.57	2.02	1.58	1.01	1.05	1.82
Price to Earnings (P/E)	0.00	65.64	23.46	20.77	19.89	17.23	23.85	12.44	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	1.52%	4.26%	4.81%	5.03%	5.80%	4.19%	8.04%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	4.68	5.20	4.13	2.81	2.48	2.28	1.92	1.54	1.84	2.89
Enterprise Value to Revenue (EV/Rev)	0.00	3.06	3.44	3.69	3.75	3.42	2.74	2.42	1.82	2.00	2.79
Enterprise Value to EBITDA (EV/EBITDA)	0.00	20.15	14.12	13.88	13.48	11.23	11.89	9.31	15.43	0.00	87.13
Enterprise Value to EBIT (EV/EBIT)	0.00	26.47	17.56	16.64	17.65	15.01	18.10	12.44	40.08	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	53.49	21.09	20.22	22.24	19.74	18.09	15.85	53.31	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	21.71	19.20	16.62	17.59	11.81	12.99	12.86	15.03	21.88	9.84
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	82.14	30.93	0.00	0.00	16.12	17.29	0.00	20.53	10.00	10.63
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.17	3.63	1.63	2.22	2.36	2.01	1.88	2.11	2.32	7.18	40.69
Long-Term Debt to Equity	0.15	3.58	1.60	2.19	2.31	1.97	1.86	2.11	2.19	6.86	39.10
Financial Leverage	0.11	0.79	2.00	1.69	2.15	1.90	1.54	1.74	2.08	3.27	10.54
Leverage Ratio	1.51	2.47	4.27	3.64	3.98	3.82	3.65	3.79	4.03	5.62	16.33
Compound Leverage Factor	1.31	2.05	3.92	3.21	3.30	3.24	2.82	3.16	-0.53	6.76	33.64
Debt to Total Capital	14.73%	78.41%	62.00%	68.96%	70.21%	66.83%	65.33%	67.85%	69.91%	87.77%	97.60%
Short-Term Debt to Total Capital	1.55%	1.20%	1.29%	1.03%	1.26%	1.34%	1.01%	0.04%	4.02%	3.84%	3.80%
Long-Term Debt to Total Capital	13.18%	77.21%	60.71%	67.93%	68.95%	65.48%	64.32%	67.80%	65.89%	83.93%	93.80%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.63%	1.22%	1.91%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	84.64%	20.37%	36.09%	31.04%	29.79%	33.17%	34.67%	32.15%	30.09%	12.23%	2.40%
Debt to EBITDA	0.47	3.55	1.91	2.49	3.48	3.49	3.96	3.41	7.35	-4.15	32.31
Net Debt to EBITDA	0.30	3.33	1.54	2.24	3.32	2.80	3.10	3.23	6.87	-3.95	30.22
Long-Term Debt to EBITDA	0.42	3.49	1.87	2.46	3.41	3.42	3.90	3.40	6.92	-3.97	31.05
Debt to NOPAT	0.93	9.42	2.86	3.63	5.74	6.14	6.03	5.80	25.38	-7.26	-39.24
Net Debt to NOPAT	0.60	8.83	2.30	3.26	5.48	4.91	4.72	5.49	23.72	-6.91	-36.70
Long-Term Debt to NOPAT	0.83	9.27	2.80	3.58	5.63	6.01	5.93	5.79	23.92	-6.94	-37.71
Altman Z-Score	0.00	3.75	4.95	4.20	2.85	2.64	2.46	2.46	1.93	0.99	1.78
Noncontrolling Interest Sharing Ratio	0.73%	1.75%	5.24%	2.27%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.97	2.16	2.41	2.31	2.15	2.81	2.70	2.25	1.81	1.87	1.33
Quick Ratio	1.27	0.88	1.23	1.07	0.96	1.82	1.63	0.99	0.77	0.79	0.60
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-479	34	108	-163	-494	258	220	-173	150	282	307
Operating Cash Flow to CapEx	71.56%	225.57%	331.37%	268.37%	240.16%	429.23%	282.56%	219.93%	186.79%	165.72%	612.20%
Free Cash Flow to Firm to Interest Expense	-23.82	1.75	5.98	-4.91	-9.04	5.48	4.26	-2.80	1.61	2.88	3.92
Operating Cash Flow to Interest Expense	3.59	6.63	9.63	7.59	5.05	7.48	5.67	5.07	2.20	1.31	4.23
Operating Cash Flow Less CapEx to Interest Expense	-1.43	3.69	6.72	4.76	2.95	5.74	3.67	2.77	1.02	0.52	3.54
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.23	1.13	1.10	1.01	0.75	0.54	0.58	0.64	0.63	0.61	0.64
Accounts Receivable Turnover	10.07	9.82	10.25	10.36	9.62	0.00	0.00	0.00	0.00	0.00	9.02
Inventory Turnover	4.59	4.22	4.14	4.08	4.02	3.74	4.09	3.81	3.79	3.55	3.70
Fixed Asset Turnover	2.19	2.11	2.26	2.36	0.00	0.00	0.00	0.00	2.17	1.98	1.87
Accounts Payable Turnover	10.54	8.80	7.93	8.15	8.45	7.38	7.64	7.31	7.32	7.53	7.57
Days Sales Outstanding (DSO)	36.26	37.17	35.62	35.24	37.96	0.00	0.00	0.00	0.00	0.00	40.47
Days Inventory Outstanding (DIO)	79.58	86.40	88.27	89.47	90.90	97.62	89.35	95.75	96.29	102.71	98.71
Days Payable Outstanding (DPO)	34.63	41.46	46.04	44.81	43.21	49.43	47.77	49.95	49.84	48.50	48.20
Cash Conversion Cycle (CCC)	81.21	82.11	77.86	79.90	85.65	48.19	41.58	45.80	46.46	54.21	90.97
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	575	593	643	1,014	1,725	1,678	1,668	2,095	2,003	1,528	1,129
Invested Capital Turnover	3.33	1.56	1.57	1.37	0.94	0.71	0.83	0.89	0.83	0.80	0.90
Increase / (Decrease) in Invested Capital	575	18	51	370	712	-47	-9.80	427	-92	-475	-338
Enterprise Value (EV)	0.00	2,776	3,347	4,187	4,849	4,162	3,811	4,029	3,082	2,814	3,259
Market Capitalization	0.00	2,310	2,968	3,512	3,655	3,126	2,817	2,632	1,711	1,481	2,128
Book Value per Share	$12.20	$3.02	$6.27	$8.07	$12.69	$15.55	$17.15	$18.69	$17.43	$5.37	$0.83
Tangible Book Value per Share	$11.68	$2.55	$5.86	$1.96	($7.22)	($4.28)	($2.69)	($6.02)	($6.41)	($7.12)	($4.19)
Total Capital	607	623	731	1,091	1,782	1,936	1,943	2,172	2,099	1,596	1,238
Total Debt	89	489	453	752	1,251	1,293	1,270	1,473	1,467	1,401	1,209
Total Long-Term Debt	80	481	444	741	1,228	1,267	1,250	1,473	1,383	1,340	1,161
Net Debt	57	458	366	675	1,194	1,036	994	1,397	1,371	1,333	1,130
Capital Expenditures (CapEx)	101	57	53	94	115	82	104	143	110	78	54
Debt-free, Cash-free Net Working Capital (DFCFNWC)	174	135	137	173	214	174	200	304	284	222	82
Debt-free Net Working Capital (DFNWC)	206	166	225	251	270	431	476	381	380	290	160
Net Working Capital (NWC)	197	158	216	239	248	405	456	380	296	229	113
Net Nonoperating Expense (NNE)	12	7.50	14	25	34	29	93	43	63	237	136
Net Nonoperating Obligations (NNO)	57	458	366	675	1,194	1,036	994	1,397	1,371	1,333	1,099
Total Depreciation and Amortization (D&A)	35	33	47	50	85	93	110	109	123	108	106
Debt-free, Cash-free Net Working Capital to Revenue	18.15%	14.90%	14.09%	15.27%	16.53%	14.28%	14.39%	18.22%	16.80%	15.81%	7.01%
Debt-free Net Working Capital to Revenue	21.49%	18.25%	23.13%	22.11%	20.90%	35.47%	34.18%	22.82%	22.46%	20.65%	13.70%
Net Working Capital to Revenue	20.51%	17.43%	22.16%	21.12%	19.16%	33.33%	32.77%	22.77%	17.48%	16.29%	9.67%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.89	$0.83	$3.00	$4.02	$4.39	$4.39	$2.97	$5.54	($0.15)	($11.85)	($4.61)
Adjusted Weighted Average Basic Shares Outstanding	42.10M	42.13M	42.08M	41.62M	41.83M	40.47M	39.00M	37.15M	36.24M	36.35M	35.29M
Adjusted Diluted Earnings per Share	$1.89	$0.83	$2.97	$3.97	$4.35	$4.37	$2.95	$5.50	($0.15)	($11.85)	($4.61)
Adjusted Weighted Average Diluted Shares Outstanding	42.10M	42.13M	42.08M	41.62M	41.83M	40.47M	39.00M	37.15M	36.24M	36.35M	35.29M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	42.10M	42.13M	42.08M	41.62M	41.83M	40.47M	39.00M	37.15M	36.24M	36.35M	35.29M
Normalized Net Operating Profit after Tax (NOPAT)	91	73	168	215	240	226	223	258	179	182	174
Normalized NOPAT Margin	9.54%	8.03%	17.25%	19.01%	18.54%	18.62%	16.02%	15.47%	10.61%	12.94%	14.93%
Pre Tax Income Margin	14.24%	9.58%	17.98%	19.57%	17.63%	19.33%	11.70%	16.16%	-0.60%	-38.08%	-12.17%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	7.79	5.44	10.53	7.58	5.03	5.89	4.07	5.24	0.82	-4.56	-0.88
NOPAT to Interest Expense	4.78	2.69	8.77	6.24	3.99	4.48	4.07	4.11	0.62	-1.97	-0.39
EBIT Less CapEx to Interest Expense	2.77	2.50	7.62	4.75	2.93	4.14	2.06	2.94	-0.35	-5.35	-1.57
NOPAT Less CapEx to Interest Expense	-0.24	-0.25	5.86	3.41	1.89	2.73	2.07	1.81	-0.56	-2.77	-1.08
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	4.03%	1,022.30%	8.47%	52.42%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	4.03%	1,022.30%	13.02%	78.49%	3.48%	48.51%	92.63%	68.62%	-1,705.56%	0.00%	-33.69%

This table displays calculated financial ratios and metrics derived from Ingevity's official financial filings.

Metric	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	35,291,884.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	35,291,884.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	1.69
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-7.47%	-3.10%	-13.37%	-18.93%	-15.49%	-19.61%	-16.50%	-6.53%	-0.21%	36.73%	4.07%
EBITDA Growth	-35.49%	-214.87%	-117.42%	-384.95%	-202.45%	203.33%	455.50%	65.33%	4.42%	-116.98%	-16.00%
EBIT Growth	-48.56%	-388.33%	-159.26%	-549.35%	-306.70%	150.97%	193.15%	60.15%	3.60%	-130.80%	-19.12%
NOPAT Growth	-48.44%	-354.88%	-123.51%	-522.64%	-103.63%	237.34%	415.89%	58.33%	-27.64%	-127.47%	20.31%
Net Income Growth	-66.58%	-848.72%	-210.45%	-899.15%	-525.40%	114.21%	136.61%	48.36%	140.58%	-609.64%	191.71%
EPS Growth	-65.15%	-834.88%	-214.07%	-905.15%	-527.54%	114.24%	136.36%	48.53%	140.14%	-629.55%	196.43%
Operating Cash Flow Growth	5.09%	-53.10%	-328.30%	-38.64%	-55.80%	39.61%	309.92%	165.99%	178.92%	50.54%	-107.87%
Free Cash Flow Firm Growth	-1,894.77%	104.08%	144.76%	164.90%	252.23%	3,471.90%	174.52%	-22.91%	-40.40%	-56.18%	18.51%
Invested Capital Growth	22.80%	-4.41%	-8.28%	-22.61%	-25.14%	-23.69%	-21.13%	-18.28%	-19.41%	-23.02%	-31.71%
Revenue Q/Q Growth	-7.43%	-16.66%	-8.50%	14.85%	-3.51%	-20.72%	-4.95%	28.56%	-8.76%	-44.34%	39.16%
EBITDA Q/Q Growth	-13.94%	-190.91%	76.08%	-1,320.50%	69.06%	191.70%	-11.79%	-238.54%	210.25%	-140.33%	257.08%
EBIT Q/Q Growth	-20.35%	-296.92%	54.37%	-527.82%	63.36%	148.55%	-16.61%	-368.61%	164.95%	-188.96%	164.30%
NOPAT Q/Q Growth	-14.00%	-271.55%	83.99%	-1,689.66%	99.26%	6,590.97%	-63.18%	-317.96%	163.98%	-173.45%	234.68%
Net Income Q/Q Growth	-29.01%	-563.49%	52.05%	-406.61%	62.21%	115.49%	23.49%	-814.63%	129.69%	-294.48%	170.69%
EPS Q/Q Growth	-28.87%	-557.97%	51.27%	-407.14%	62.23%	115.25%	24.44%	-817.86%	129.35%	-297.46%	171.24%
Operating Cash Flow Q/Q Growth	117.36%	-56.08%	-127.13%	345.45%	56.57%	38.71%	-60.62%	211.02%	64.18%	-25.13%	-102.06%
Free Cash Flow Firm Q/Q Growth	17.58%	104.67%	923.57%	64.61%	93.32%	9.66%	-21.33%	-50.94%	61.05%	-17.16%	83.33%
Invested Capital Q/Q Growth	-3.02%	-4.95%	-1.48%	-14.78%	-6.19%	-3.11%	1.83%	-11.70%	-7.50%	-11.22%	-5.83%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	28.92%	16.01%	29.31%	31.54%	34.47%	34.10%	39.93%	37.77%	40.20%	41.15%	45.12%
EBITDA Margin	19.24%	-20.98%	-5.88%	-72.73%	-23.32%	26.97%	25.04%	-26.98%	32.60%	-23.62%	26.67%
Operating Margin	12.67%	-29.24%	-5.12%	-79.72%	-0.61%	18.54%	17.71%	-32.81%	24.56%	-30.37%	26.55%
EBIT Margin	12.38%	-29.24%	-14.58%	-79.72%	-30.27%	18.54%	16.27%	-33.99%	24.20%	-38.67%	17.87%
Profit (Net Income) Margin	5.65%	-31.42%	-16.47%	-72.63%	-28.44%	5.56%	7.22%	-40.13%	13.06%	-45.63%	23.18%
Tax Burden Percent	78.50%	75.84%	77.89%	84.79%	77.74%	188.64%	76.49%	102.66%	69.94%	95.70%	198.01%
Interest Burden Percent	58.15%	141.67%	144.96%	107.45%	120.86%	15.88%	58.01%	114.99%	77.17%	123.29%	65.51%
Effective Tax Rate	21.50%	0.00%	0.00%	0.00%	0.00%	-88.64%	23.51%	0.00%	34.41%	0.00%	22.52%
Return on Invested Capital (ROIC)	8.87%	-16.91%	-2.85%	-44.84%	-0.34%	27.86%	10.37%	-19.92%	14.98%	-19.13%	18.50%
ROIC Less NNEP Spread (ROIC-NNEP)	7.32%	-19.85%	-5.94%	-49.45%	-8.02%	21.36%	9.05%	-24.65%	14.16%	-22.95%	19.08%
Return on Net Nonoperating Assets (RNNOA)	13.36%	-41.32%	-13.00%	-141.33%	-23.64%	69.88%	30.73%	-161.06%	100.24%	-241.77%	163.58%
Return on Equity (ROE)	22.23%	-58.22%	-15.85%	-186.17%	-23.98%	97.75%	41.10%	-180.98%	115.22%	-260.90%	182.09%
Cash Return on Invested Capital (CROIC)	-11.24%	7.33%	8.63%	11.65%	12.04%	15.95%	15.38%	18.27%	19.40%	23.64%	35.94%
Operating Return on Assets (OROA)	8.27%	-18.46%	-8.96%	-48.37%	-17.99%	11.23%	9.50%	-21.68%	15.84%	-24.58%	11.36%
Return on Assets (ROA)	3.77%	-19.84%	-10.11%	-44.06%	-16.90%	3.36%	4.22%	-25.59%	8.55%	-29.01%	14.73%
Return on Common Equity (ROCE)	22.23%	-58.22%	-15.85%	-186.17%	-23.98%	97.75%	41.10%	-180.98%	115.22%	-260.90%	182.09%
Return on Equity Simple (ROE_SIMPLE)	17.67%	0.00%	-19.73%	-151.44%	-262.80%	0.00%	-150.81%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	44	-76	-12	-218	-1.61	105	38	-84	54	-39	53
NOPAT Margin	9.95%	-20.47%	-3.58%	-55.81%	-0.43%	34.97%	13.55%	-22.97%	16.11%	-21.26%	20.57%
Net Nonoperating Expense Percent (NNEP)	1.55%	2.94%	3.10%	4.60%	7.68%	6.50%	1.32%	4.73%	0.81%	3.81%	-0.57%
Return On Investment Capital (ROIC_SIMPLE)	-	-3.63%	-	-	-	6.55%	2.36%	-5.78%	3.84%	-3.18%	4.27%
Cost of Revenue to Revenue	71.08%	83.99%	70.69%	68.46%	65.53%	65.90%	60.07%	62.23%	59.80%	58.85%	54.88%
SG&A Expenses to Revenue	8.97%	11.68%	13.88%	10.60%	10.27%	13.19%	15.18%	12.11%	13.24%	21.47%	15.78%
R&D to Revenue	1.75%	1.94%	2.00%	1.87%	1.78%	2.44%	2.71%	2.14%	2.10%	3.18%	2.60%
Operating Expenses to Revenue	16.26%	45.25%	34.43%	111.26%	35.08%	15.56%	22.22%	70.58%	15.64%	71.52%	18.57%
Earnings before Interest and Taxes (EBIT)	55	-109	-50	-311	-114	55	46	-124	81	-72	46
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	86	-78	-20	-284	-88	81	71	-99	109	-44	69
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.40	2.71	3.04	5.58	6.61	7.59	6.13	13.02	14.57	71.66	64.62
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	1.01	1.01	1.05	1.03	0.96	1.05	1.07	1.19	1.52	1.82	2.13
Price to Earnings (P/E)	13.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	7.36%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.48	1.54	1.59	1.78	1.76	1.84	1.77	2.06	2.51	2.89	3.33
Enterprise Value to Revenue (EV/Rev)	1.83	1.82	1.91	1.93	1.88	2.00	2.04	2.13	2.41	2.79	3.00
Enterprise Value to EBITDA (EV/EBITDA)	8.90	15.43	48.28	0.00	0.00	0.00	0.00	0.00	0.00	87.13	49.34
Enterprise Value to EBIT (EV/EBIT)	13.69	40.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	17.64	53.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	12.09	15.03	16.69	17.66	25.21	21.88	16.62	13.11	10.68	9.84	11.64
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	20.53	17.61	13.30	12.54	10.00	10.17	10.12	11.55	10.63	7.52
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	2.05	2.32	2.63	5.28	6.99	7.18	5.94	11.02	9.13	40.69	30.96
Long-Term Debt to Equity	2.04	2.19	2.48	4.92	6.52	6.86	5.68	10.24	8.39	39.10	27.83
Financial Leverage	1.83	2.08	2.19	2.86	2.95	3.27	3.40	6.54	7.08	10.54	8.58
Leverage Ratio	3.77	4.03	4.13	5.11	5.33	5.62	5.76	10.24	11.47	16.33	13.55
Compound Leverage Factor	2.19	5.71	5.98	5.49	6.45	0.89	3.34	11.78	8.85	20.14	8.88
Debt to Total Capital	67.20%	69.91%	72.44%	84.08%	87.48%	87.77%	85.59%	91.68%	90.13%	97.60%	96.87%
Short-Term Debt to Total Capital	0.14%	4.02%	4.11%	5.76%	5.88%	3.84%	3.71%	6.53%	7.29%	3.80%	9.81%
Long-Term Debt to Total Capital	67.07%	65.89%	68.33%	78.32%	81.60%	83.93%	81.88%	85.16%	82.83%	93.80%	87.07%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	32.80%	30.09%	27.56%	15.92%	12.52%	12.23%	14.41%	8.32%	9.87%	2.40%	3.13%
Debt to EBITDA	4.21	7.35	23.01	-5.72	-4.60	-4.15	-5.66	-21.99	-22.55	32.31	16.80
Net Debt to EBITDA	3.97	6.87	21.65	-5.31	-4.18	-3.95	-5.37	-20.72	-21.06	30.22	14.28
Long-Term Debt to EBITDA	4.20	6.92	21.71	-5.33	-4.29	-3.97	-5.41	-20.42	-20.72	31.05	15.10
Debt to NOPAT	8.35	25.38	-7,111.43	-5.64	-4.87	-7.26	-9.57	-47.16	-42.07	-39.24	-52.94
Net Debt to NOPAT	7.87	23.72	-6,690.00	-5.24	-4.43	-6.91	-9.08	-44.43	-39.29	-36.70	-45.00
Long-Term Debt to NOPAT	8.33	23.92	-6,708.10	-5.25	-4.54	-6.94	-9.15	-43.80	-38.67	-37.71	-47.58
Altman Z-Score	1.94	1.69	1.76	1.29	1.43	1.80	1.76	1.45	2.03	1.78	2.26
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.41	1.81	1.90	1.92	1.77	1.87	2.00	1.36	1.27	1.33	1.42
Quick Ratio	0.99	0.77	0.80	0.90	0.90	0.79	0.89	0.69	0.61	0.60	0.60
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-347	16	166	273	528	579	455	223	360	298	546
Operating Cash Flow to CapEx	314.03%	158.22%	-72.89%	164.09%	258.33%	259.04%	396.88%	647.54%	1,089.92%	411.44%	-19.42%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.67	0.63	0.61	0.61	0.59	0.61	0.58	0.64	0.65	0.64	0.64
Accounts Receivable Turnover	0.00	0.00	7.60	6.55	7.28	0.00	7.61	6.51	7.40	9.02	7.48
Inventory Turnover	3.55	3.79	3.49	3.30	3.29	3.55	3.09	3.22	3.69	3.70	3.17
Fixed Asset Turnover	2.24	2.17	2.14	2.03	2.01	1.98	1.95	1.92	2.04	1.87	1.88
Accounts Payable Turnover	6.56	7.32	7.33	6.57	7.26	7.53	6.75	6.90	8.50	7.57	7.36
Days Sales Outstanding (DSO)	0.00	0.00	48.05	55.76	50.15	0.00	47.98	56.04	49.34	40.47	48.80
Days Inventory Outstanding (DIO)	102.85	96.29	104.61	110.61	110.78	102.71	118.14	113.25	98.94	98.71	115.14
Days Payable Outstanding (DPO)	55.68	49.84	49.80	55.54	50.25	48.50	54.09	52.88	42.95	48.20	49.57
Cash Conversion Cycle (CCC)	47.17	46.46	102.86	110.83	110.68	54.21	112.03	116.40	105.33	90.97	114.37
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,107	2,003	1,973	1,681	1,577	1,528	1,556	1,374	1,271	1,129	1,063
Invested Capital Turnover	0.89	0.83	0.80	0.80	0.80	0.80	0.77	0.87	0.93	0.90	0.90
Increase / (Decrease) in Invested Capital	391	-92	-178	-491	-530	-475	-417	-307	-306	-338	-493
Enterprise Value (EV)	3,113	3,082	3,133	2,985	2,780	2,814	2,761	2,825	3,190	3,259	3,538
Market Capitalization	1,725	1,711	1,728	1,588	1,417	1,481	1,439	1,571	2,013	2,128	2,514
Book Value per Share	$19.84	$17.43	$15.64	$7.84	$5.90	$5.37	$6.45	$3.31	$3.79	$0.83	$1.10
Tangible Book Value per Share	($4.89)	($6.41)	($7.17)	($5.17)	($7.46)	($7.12)	($6.13)	($4.46)	($3.67)	($4.19)	($3.78)
Total Capital	2,191	2,099	2,062	1,789	1,713	1,596	1,628	1,451	1,399	1,238	1,243
Total Debt	1,473	1,467	1,493	1,504	1,498	1,401	1,393	1,330	1,261	1,209	1,204
Total Long-Term Debt	1,470	1,383	1,409	1,401	1,398	1,340	1,333	1,236	1,159	1,161	1,082
Net Debt	1,388	1,371	1,405	1,397	1,363	1,333	1,322	1,253	1,177	1,130	1,024
Capital Expenditures (CapEx)	34	29	17	18	18	25	6.40	12	12	24	10
Debt-free, Cash-free Net Working Capital (DFCFNWC)	348	284	314	324	241	222	254	161	129	82	114
Debt-free Net Working Capital (DFNWC)	432	380	402	431	377	290	326	238	213	160	294
Net Working Capital (NWC)	429	296	318	328	276	229	265	143	111	113	172
Net Nonoperating Expense (NNE)	19	41	44	66	106	88	18	63	10	45	-6.72
Net Nonoperating Obligations (NNO)	1,388	1,371	1,405	1,397	1,363	1,333	1,322	1,253	1,133	1,099	1,024
Total Depreciation and Amortization (D&A)	31	31	30	27	26	25	25	26	28	28	23
Debt-free, Cash-free Net Working Capital to Revenue	20.42%	16.80%	19.13%	20.90%	16.31%	15.81%	18.83%	12.13%	9.76%	7.01%	9.66%
Debt-free Net Working Capital to Revenue	25.38%	22.46%	24.53%	27.84%	25.46%	20.65%	24.13%	17.93%	16.06%	13.70%	24.99%
Net Working Capital to Revenue	25.20%	17.48%	19.36%	21.18%	18.66%	16.29%	19.65%	10.79%	8.35%	9.67%	14.64%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.70	($3.19)	($1.54)	($7.81)	($2.95)	$0.45	$0.56	($4.02)	$1.20	($2.35)	$1.70
Adjusted Weighted Average Basic Shares Outstanding	36.23M	36.24M	36.33M	36.35M	36.35M	36.35M	36.46M	36.47M	35.96M	35.29M	34.77M
Adjusted Diluted Earnings per Share	$0.69	($3.16)	($1.54)	($7.81)	($2.95)	$0.45	$0.56	($4.02)	$1.18	($2.33)	$1.66
Adjusted Weighted Average Diluted Shares Outstanding	36.23M	36.24M	36.33M	36.35M	36.35M	36.35M	36.46M	36.47M	35.96M	35.29M	34.77M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	36.23M	36.24M	36.33M	36.35M	36.35M	36.35M	36.46M	36.47M	35.96M	35.29M	34.77M
Normalized Net Operating Profit after Tax (NOPAT)	64	12	-12	35	59	99	38	45	54	-39	53
Normalized NOPAT Margin	14.29%	3.30%	-3.52%	9.07%	15.69%	33.24%	13.55%	12.27%	16.11%	-21.26%	20.72%
Pre Tax Income Margin	7.20%	-41.43%	-21.14%	-85.66%	-36.59%	2.95%	9.44%	-39.09%	18.67%	-47.68%	11.71%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	77.24%	-1,705.56%	-52.36%	0.00%	0.00%	0.00%	0.00%	0.00%	-38.24%	-33.69%	-84.98%

Financials Breakdown Chart

Key Financial Trends

Here are the key takeaways from Ingevity's quarterly statements (NGVT) across the last four years, focused on trends in revenue, profitability, cash flow, and balance sheet health. The items are organized to highlight positives first, then neutral points, and finally negatives.

Operating cash flow from continuing operating activities turned positive in 2025, with about $129.7M in Q3 2025 and $97.1M in Q4 2025, signaling improving operating cash generation.
Gross margin expanded in Q4 2025 to roughly 41% (76.3M gross profit on 185.4M revenue) versus about 34% in Q4 2024, indicating better profitability on a per-dollar basis.
Q3 2025 delivered a positive quarterly net income to common shareholders (~$43.5M) and a positive diluted EPS (~$1.18), showing a profitable quarter despite volatility.
The company retains a substantial asset base, with total assets around $1.8B in recent periods, supporting balance-sheet cushion and potential for future liquidity management.
Revenue remains volatile and is down overall in 2025 vs earlier years, with Q4 2025 revenue of $185.4M versus peaks above $480M in 2022, reflecting ongoing market headwinds.
Debt remains a prominent portion of capitalization, with long-term debt generally in the $1.15B–$1.58B range across periods, indicating ongoing leverage and refinancing needs.
Cash flow from financing activities has been negative across many quarters, suggesting emphasis on debt service and potential share repurchases rather than equity fundraising, which can limit near-term liquidity flexibility.
Q4 2025 net income to common shareholders fell to -$84.6M, marking a quarterly loss and contributing to an unfavorable earnings trajectory.
Total net income shows sizable volatility with several periods reporting losses or substantial margin pressure, underscoring ongoing profitability challenges in a cyclical end-market.
Net change in cash and equivalents was negative in multiple quarters (e.g., Q3 2025: -$83.4M; Q4 2025: -$19.8M), signaling ongoing cash burn during periods despite positive operating cash flow in other quarters.

05/14/26 05:58 PM ETAI Generated. May Contain Errors.

Ingevity Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Ingevity's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Ingevity's net income appears to be on a downward trend, with a most recent value of -$167.10 million in 2025, falling from $84.30 million in 2015. The previous period was -$430.30 million in 2024. Find out what analysts predict for Ingevity in the coming months.

Ingevity's total operating income in 2025 was -$44 million, based on the following breakdown:

Total Gross Profit: $461.50 million
Total Operating Expenses: $505.50 million

Over the last 10 years, Ingevity's total revenue changed from $958.30 million in 2015 to $1.17 billion in 2025, a change of 21.8%.

Ingevity's total liabilities were at $1.62 billion at the end of 2025, a 11.3% decrease from 2024, and a 520.5% increase since 2015.

In the past 10 years, Ingevity's cash and equivalents has ranged from $30.50 million in 2016 to $275.40 million in 2021, and is currently $78.10 million as of their latest financial filing in 2025.

Over the last 10 years, Ingevity's book value per share changed from 12.20 in 2015 to 0.83 in 2025, a change of -93.2%.

Related Companies

Financial statements for NYSE:NGVT last updated on 5/8/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ingevity (NGVT) Financials

Financials Breakdown Chart

Key Financial Trends

Ingevity Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Ingevity (NGVT) Financials

Annual Income Statements for Ingevity

Quarterly Income Statements for Ingevity

Annual Cash Flow Statements for Ingevity

Quarterly Cash Flow Statements for Ingevity

Annual Balance Sheets for Ingevity

Quarterly Balance Sheets for Ingevity

Annual Metrics And Ratios for Ingevity

Quarterly Metrics And Ratios for Ingevity

Financials Breakdown Chart

Key Financial Trends

Ingevity Financials - Frequently Asked Questions

When does Ingevity's financial year end?

How has Ingevity's net income changed over the last 10 years?

What is Ingevity's operating income?

How has Ingevity's revenue changed over the last 10 years?

How much debt does Ingevity have?

How much cash does Ingevity have?

How has Ingevity's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools